Details
Description
This report describes the utilization of ibrexafungerp during pregnancy among patients with live-birth deliveries and describes demographic and pregnancy characteristics among all pregnant patients as well as among pregnant patients with ibrexafungerp use during pregnancy.
The study period includes data from June 1, 2021 to November 30, 2022. We distributed this request to six Rapid Sentinel Data Partners on January 4, 2023.